HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term renal tubular damage in intrauterine growth-restricted rats.

AbstractBACKGROUND:
Intrauterine growth restriction (IUGR) has been shown to be associated with increased risk of renal disease or hypertension in later life. Glomerular dysfunction, however, has mainly been reported, and limited information is available to link IUGR with renal tubular damage. The aim of this study was therefore to investigate urinary markers of tubular damage in a rat model of IUGR induced by bilateral uterine artery ligation.
METHODS:
Pregnant Sprague-Dawley rats underwent bilateral uterine artery ligation, while the control group underwent sham surgery.
RESULTS:
Birthweight was reduced, and urinary β2-microglobulin (β2-MG)-, cystatin C (Cys-C)-, and calbindin-to-creatinine ratios were significantly higher at weeks 4 and 8 in the IUGR group compared with the control group. These urinary markers were not significantly different at week 16 between the two groups. Increased excretion of urinary β2-MG, Cys-C, and calbindin was observed in IUGR rats at ≥8 weeks of age.
CONCLUSION:
Children born with IUGR are at increased risk for renal tubular damage.
AuthorsYayoi Murano, Hiromichi Shoji, Taichi Hara, Naho Ikeda, Amane Endo, Naoto Nishizaki, Toshiaki Shimizu
JournalPediatrics international : official journal of the Japan Pediatric Society (Pediatr Int) Vol. 60 Issue 6 Pg. 565-568 (Jun 2018) ISSN: 1442-200X [Electronic] Australia
PMID29575245 (Publication Type: Journal Article)
Copyright© 2018 Japan Pediatric Society.
Chemical References
  • Biomarkers
Topics
  • Animals
  • Biomarkers (metabolism)
  • Female
  • Fetal Growth Retardation (metabolism, physiopathology)
  • Kidney Tubules (physiopathology)
  • Ligation
  • Male
  • Pregnancy
  • Rats
  • Rats, Sprague-Dawley
  • Renal Insufficiency (diagnosis, etiology, metabolism)
  • Uterine Artery (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: